BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12843931)

  • 21. [Non-alcoholic steatohepatitis].
    Duvnjak M; Virović L
    Acta Med Croatica; 2003; 57(3):189-99. PubMed ID: 14582465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of non-alcoholic steatohepatitis.
    McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
    Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J; Cayón A; Pons-Romero F
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.
    Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
    Clin Biochem; 2005 Mar; 38(3):203-17. PubMed ID: 15708540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.
    Pessayre D; Mansouri A; Fromenty B
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G193-9. PubMed ID: 11804839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Abdominal obesity: metabolic complications and consequences for the liver].
    De Vries AP; Bakker SJ; Gans RO
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1910-1. PubMed ID: 11605319
    [No Abstract]   [Full Text] [Related]  

  • 29. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes.
    Nadeau K; Klingensmith G; Sokol RJ
    Curr Opin Pediatr; 2003 Feb; 15(1):127-31. PubMed ID: 12544284
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic and nutritional considerations in nonalcoholic fatty liver.
    Fong DG; Nehra V; Lindor KD; Buchman AL
    Hepatology; 2000 Jul; 32(1):3-10. PubMed ID: 10869282
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonalcoholic steatohepatitis: a review].
    Jacquemin G
    Rev Med Liege; 2003 Mar; 58(3):147-54. PubMed ID: 12723508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and fatty liver: guilty by association?
    Brookes MJ; Cooper BT
    J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
    Farrell GC
    J Gastroenterol Hepatol; 2003 Feb; 18(2):124-38. PubMed ID: 12542595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
    Bradbury MW
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
    Ginsberg HN
    Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of and therapy for nonalcoholic steatohepatitis].
    Onishi S; Saibara T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1876-80. PubMed ID: 17037330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.